![Ben Bronstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ben Bronstein
Direktor/Vorstandsmitglied bei
ALDEYRA THERAPEUTICS, INC.
Vermögen: 41 807 $ am 31.08.2026
Profil
Ben R.
Bronstein is the founder of Peptimmune, Inc., founded in 1995.
Dr. Bronstein was the founder of OPKO Health, Inc., founded in 2008, and served as Vice President-Research & Development from 2008 to 2009.
Dr. Bronstein was the founder of Vidus Ocular, Inc., founded in 2006, and served as President.
Dr. Bronstein was the founder of Access BridgeGap Ventures, founded in 2011, and served as Senior Vice President from 2011 to 2013.
Dr. Bronstein is also the founder of BioSurface Technology, Inc...
Dr. Bronstein is currently an Independent Director at Aldeyra Therapeutics, Inc. since 2010.
Dr. Bronstein is currently a Director at Helio Vision, Inc. Former positions include Non-Executive Chairman at Cleveland Diagnostics, Inc., Managing Director at Zero Stage Capital Co., Inc. from 2003 to 2005, Director at eXIthera Pharmaceuticals, Inc., Executive Vice President-Clinical Development at Aclaris Therapeutics, Inc. from 2017 to 2018, Advisor at Echelon Ventures, Chief Medical Officer at Sentien Biotechnologies, Inc. from 2016 to 2017, Principal at Cold Spring Venture Advisors LLC, and Chief Medical Officer at Stealth BioTherapeutics Corp.
from 2014 to 2015.
Education includes undergraduate, MBA, and doctorate degrees from Boston University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2026 | 28.248 ( 0,05 % ) | 41 807 $ | 31.08.2026 |
Aktive Positionen von Ben Bronstein
| Unternehmen | Position | Beginn |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.06.2010 |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Develop a therapy for fibro proliferative disorders that lead to abnormal scarring and blindness after retina surgery | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ben Bronstein
| Unternehmen | Position | Ende |
|---|---|---|
Cleveland Diagnostics, Inc.
 Cleveland Diagnostics, Inc. Medical/Nursing ServicesHealth Services Provides cancer testing services | Vorsitzender | 01.01.2024 |
Cold Spring Venture Advisors LLC
 Cold Spring Venture Advisors LLC Investment ManagersFinance Provides investment management services | Corporate Officer/Principal | 28.06.2019 |
| ACLARIS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2018 |
Sentien Biotechnologies, Inc.
 Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Develops cell-based therapy | Corporate Officer/Principal | 01.01.2017 |
| STEALTH BIOTHERAPEUTICS CORP | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2015 |
Ausbildung von Ben Bronstein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Zero Stage Capital Co., Inc.
 Zero Stage Capital Co., Inc. Investment ManagersFinance Zero Stage invests in emerging growth companies in technology sectors, including information technology, communications, life sciences and energy technology. The firm primarily invests in companies located along the east coast of the US. | Finance |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures stroke prevention & antithrombosis drugs | Health Technology |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioSurface Technology, Inc.
 BioSurface Technology, Inc. Miscellaneous Commercial ServicesCommercial Services Commercial biotechnical research | Commercial Services |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Echelon Ventures
 Echelon Ventures Investment ManagersFinance Echelon Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
OPKO Health, Inc.
 OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Vidus Ocular, Inc.
 Vidus Ocular, Inc. Medical SpecialtiesHealth Technology Manufactures shunts to treat glaucoma | Health Technology |
Access BridgeGap Ventures
 Access BridgeGap Ventures Investment ManagersFinance Access Bridgegap Ventures seeks to bridge the early-stage investment gap in the therapeutics space. The firm leverages their experience in start-up creation, technology commercialization and venture investing to fund young start-ups and create de novo spin-offs around potential high-impact technologies, many of which are still in academic research labs. | Finance |
Sentien Biotechnologies, Inc.
Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Develops cell-based therapy | Health Technology |
Cleveland Diagnostics, Inc.
Cleveland Diagnostics, Inc. Medical/Nursing ServicesHealth Services Provides cancer testing services | Health Services |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Develop a therapy for fibro proliferative disorders that lead to abnormal scarring and blindness after retina surgery | Health Technology |
Cold Spring Venture Advisors LLC
Cold Spring Venture Advisors LLC Investment ManagersFinance Provides investment management services | Finance |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
